GV-1301

N/A

Report date: 2023/10/26 16:14:37

Base Information

Drug NameGV-1301

Drug Alias NameGV 1301Cytosine deaminase gene therapy-GenVecGV-1301

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionCytosine deaminase modulators

TargetsCytosine deaminase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenvec Llc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenvec Llc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A